Evidence map›Paper›PMID 27877890›Full record

ArticleScience and technology of advanced materials2016

X-ray computed tomography imaging of a tumor with high sensitivity using gold nanoparticles conjugated to a cancer-specific antibody via polyethylene glycol chains on their surface.

Tomohiko Nakagawa, Kohsuke Gonda, Takashi Kamei, Liman Cong, Yoh Hamada, Narufumi Kitamura, Hiroshi Tada, Takanori Ishida, Takuji Aimiya, Naoko Furusawa and 2 more

Open access · goldAbstract read
In one paragraph

Article in Science and technology of advanced materials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Probing the biological obstacles of nanomedicine with gold nanoparticles.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2019
    Review
  11. Medical imaging modalities using nanoprobes for cancer diagnosis: A literature review on recent findings.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2019
    Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Tomohiko NakagawaDepartment of Nano-Medical Science, Graduate School of Medicine, Tohoku University , Sendai , Japan.
Kohsuke GondaDepartment of Nano-Medical Science, Graduate School of Medicine, Tohoku University, Sendai, Japan; Department of Medical Physics, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Takashi KameiDepartment of Advanced Surgical Science and Technology, Graduate School of Medicine, Tohoku University , Sendai , Japan.
Liman CongDepartment of Nano-Medical Science, Graduate School of Medicine, Tohoku University , Sendai , Japan.
Yoh HamadaDepartment of Nano-Medical Science, Graduate School of Medicine, Tohoku University , Sendai , Japan.
Narufumi KitamuraDepartment of Nano-Medical Science, Graduate School of Medicine, Tohoku University , Sendai , Japan.
Hiroshi TadaDepartment of Surgical Oncology, Graduate School of Medicine, Tohoku University , Sendai , Japan.
Takanori IshidaDepartment of Surgical Oncology, Graduate School of Medicine, Tohoku University , Sendai , Japan.
Takuji AimiyaDevelopment Department 4, Business Development Division, Business Development Headquarters, Konica Minolta, Inc. , Tokyo , Japan.
Naoko FurusawaDevelopment Department 4, Business Development Division, Business Development Headquarters, Konica Minolta, Inc. , Tokyo , Japan.
Yasushi NakanoDevelopment Department 4, Business Development Division, Business Development Headquarters, Konica Minolta, Inc. , Tokyo , Japan.
Noriaki OhuchiDepartment of Nano-Medical Science, Graduate School of Medicine, Tohoku University, Sendai, Japan; Department of Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Tohoku University · JPKonica Minolta (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Contrast agents are often used to enhance the contrast of X-ray computed tomography (CT) imaging of tumors to improve diagnostic accuracy. However, because the iodine-based contrast agents currently used in hospitals are of low molecular weight, the agent is rapidly excreted from the kidney or moves to extravascular tissues through the capillary vessels, depending on its concentration gradient. This leads to nonspecific enhancement of contrast images for tissues. Here, we created gold (Au) nanoparticles as a new contrast agent to specifically image tumors with CT using an enhanced permeability and retention (EPR) effect. Au has a higher X-ray absorption coefficient than does iodine. Au nanoparticles were supported with polyethylene glycol (PEG) chains on their surface to increase the blood retention and were conjugated with a cancer-specific antibody via terminal PEG chains. The developed Au nanoparticles were injected into tumor-bearing mice, and the distribution of Au was examined with CT imaging, transmission electron microscopy, and elemental analysis using inductively coupled plasma optical emission spectrometry. The results show that specific localization of the developed Au nanoparticles in the tumor is affected by a slight difference in particle size and enhanced by the conjugation of a specific antibody against the tumor.

Indexed as

30 Bio-inspired and biomedical materials504 X-ray / Neutron diffraction and scatteringcontrast agentCTgoldnanoparticletumor

Identifiers

PMID27877890
PMCPMC5101864
OpenAlexW2498825285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.